ESR1 and breast carcinoma: β-glucuronidase promotes estrogen receptor binding, and activation of these receptors promotes proliferation—an action well described in the pathogenesis of breast cancer—demonstrating the exchange between estrogen levels and the gut microbiota in hormone-dependent tumors such as breast cancer and endometrial cancer [66].